Custom Synthesis Programs 2022

Ponesimod (ACT-128800) by Nutrabiotech, potent oral bioavailable S1P1 agonist for multiple sclerosis and immune regulation pharmaceutical research
SB-334867 by Nutrabiotech, potent orexin 1 receptor antagonist for sleep disorder and neurobehavioral pharmaceutical research
AG-636 by Nutrabiotech, potent orally active DHODH inhibitor for lymphoma and hematological malignancy pharmaceutical research
GDC-0077 (Inavolisib) by Nutrabiotech, potent oral bioavailable PI3Kα inhibitor for mutant PIK3CA breast cancer pharmaceutical research
BDP9066 by Nutrabiotech, potent Cdc42-binding kinase inhibitor for glioblastoma and tumor invasion pharmaceutical research
Ponesimod CAS 854107-55-4
SB-334867 CAS 792173-99-0
AG-636 CAS 1623416-31-8
GDC-0077 CAS 2060571-02-8
BDP9066 CAS 2226507-04-4
Oliceridine by Nutrabiotech, potent G-protein biased mu-opioid agonist for postoperative acute pain and anesthetic pharmaceutical research
GSK2881078 by Nutrabiotech, potent oral bioavailable SARM androgen receptor agonist for muscle wasting and cachexia pharmaceutical research
Pluripotin (SC1) by Nutrabiotech, potent dual ERK1 and RasGAP inhibitor for embryonic stem cell self-renewal and oncology research
GSK620 by Nutrabiotech, potent orally active pan-BD2 inhibitor for BET bromodomain and inflammatory pharmaceutical research
SNDX-5613 (Revumenib) by Nutrabiotech, potent Menin-MLL PPI inhibitor for MLL-r AML and ALL leukemia pharmaceutical research
Oliceridine CAS 1401031-39-7
GSK2881078 CAS 1539314-06-1
Pluripotin CAS 839707-37-8
GSK620 CAS 2088410-46-0
SNDX-5613 CAS 2169919-21-3
GM6001 (Ilomastat) by Nutrabiotech, potent matrix metalloproteinase inhibitor for anti-inflammation and tumor invasion pharmaceutical research
YC-1 by Nutrabiotech, potent HIF-1α and sGC activator for anti-angiogenesis and oncology pharmaceutical research
GSK1016790A by Nutrabiotech, potent transient receptor potential vanilloid 4 agonist for ion channel and physiological pharmaceutical research
UVI 3003 by Nutrabiotech, potent retinoid X receptor alpha antagonist for lipid metabolism and developmental biology pharmaceutical research
Licogliflozin (LIK066) by Nutrabiotech, potent oral dual sodium-glucose cotransporter inhibitor for diabetes and obesity pharmaceutical research
GM6001 CAS 142880-36-2
YC-1 CAS 170632-47-0
GSK1016790A CAS 942206-85-1
UVI 3003 CAS 847239-17-2
Licogliflozin CAS 1291094-73-9
JH-X-119-01 by Nutrabiotech, potent irreversible IRAK1 inhibitor for inflammation and lymphoma pharmaceutical research
GKN-43736 by Nutrabiotech, potent mutant HTT degrader compound targeting HTT-LC3 interaction for neurodegenerative pharmaceutical research
DDO-5936 by Nutrabiotech, potent selective Hsp90-Cdc37 protein interaction inhibitor for colorectal cancer pharmaceutical research
SEN-12333 (WAY-317538) by Nutrabiotech, orally active dual α7 nAChR agonist and H3 antagonist for cognitive and neuroinflammation research
YKL-5-124 by Nutrabiotech, potent irreversible CDK7 inhibitor for cell cycle regulation and oncology pharmaceutical research
JH-X-119-01 CAS 2227368-54-7
GKN-43736 CAS 486443-73-6
DDO-5936  CAS 2355377-13-6
SEN-12333  CAS 874450-44-9
YKL-5-124 CAS 1957203-01-8